Graf Akcie CSBR (Champions Oncology Inc). Diskuze k akciím CSBR. Aktuální informace CSBR.

Základní informace o společnosti Champions Oncology Inc (Akcie CSBR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 135.37M
Hodnota podniku (EV) N/A
Tržby 42.746M
EBITDA N/A
Zisk 115.000k
Růst v tržbách Q/Q 17.87 %
Růst v tržbách Y/Y 22.37 %
P/E (Cena vůči ziskům) 507.00
Forward P/E 6.05
EV/Sales 3.70
EV/EBITDA N/A
EV/EBIT N/A
PEG 22.13
Price/Sales 3.17
P/FCF N/A
Price/Book 18.22
Účetní hodnota na akcii 0.56
Hotovost na akcii 0.35
FCF vůči ceně -3.12 %
Počet zaměstnanců 143
Tržba na zaměstnance 298.923k
Profit margin 0.88 %
Operating margin 0.39 %
Gross margin 47.74 %
EBIT margin 0.45 %
EBITDA margin -0.64 %
EPS - Zisk na akcii 0.02
EPS - Kvartální růst -71.43 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets 0.43 %
Return on equity 1.55 %
ROIC 1.81 %
ROCE 1.16 %
Dluhy/Equity 2.71
Čistý dluh/EBITDA 25.70
Current ratio 1.08
Quick Ratio 1.08
Volatilita 3.00
Beta 1.10
RSI 48.43
Cílová cena analytiků 11
Známka akcie (dle analytiků) 1.00
Insider ownership 20.68 %
Institutional ownership 73.00 %
Počet akcií 13.422M
Procento shortovaných akcií 6.86 %
Short ratio 22.63 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2003
Země United States

Finanční výsledky akcie CSBR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$32.123$27.067$20.241$15.411$11.182$8.863
Cost Of Goods Sold$16.882$14.265$10.553$9.703$8.686$7.633
Gross Profit$15.241$12.802$9.688$5.708$2.496$1.23
Research And Development Expenses$5.853$4.798$4.401$4.293$4.194$4.845
SG&A Expenses$10.856$7.734$6.641$8.224$8.618$9.623
Other Operating Income Or Expenses------
Operating Expenses$33.926$26.797$21.595$22.22$21.498$22.101
Operating Income$-1.803$0.27$-1.354$-6.809$-10.316$-13.238
Total Non-Operating Income/Expense$-0.042$-0.039$-0.089$-0.056$-0.038$0.225
Pre-Tax Income$-1.845$0.231$-1.443$-6.865$-10.354$-13.013
Income Taxes$0.13$0.103$0.033$0.019$0.092$0.127
Income After Taxes$-1.975$0.128$-1.476$-6.884$-10.446$-13.14
Other Income------
Income From Continuous Operations$-1.975$0.128$-1.476$-6.884$-10.446$-13.14
Income From Discontinued Operations------
Net Income$-1.975$0.128$-1.476$-6.884$-10.446$-13.14
EBITDA$-0.643$0.876$-0.994$-6.641$-10.16$-13.024
EBIT$-1.803$0.27$-1.354$-6.809$-10.316$-13.238
Basic Shares Outstanding1211111196
Shares Outstanding1214111196
Basic EPS$-0.17$0.01$-0.13$-0.64$-1.20$-2.20
EPS - Earnings Per Share$-0.17$0.01$-0.13$-0.64$-1.20$-2.20
# 2020 2019 2018 2017 2016 2015
Current Ratio1.11680.98720.67890.78810.81792.8354
Long-term Debt / Capital--0.85---
Debt/Equity Ratio0.02350.007114.3333---
Gross Margin47.445847.297447.863237.038522.321613.8779
Operating Margin-5.61280.9975-6.6894-44.1827-92.2554-149.3625
EBIT Margin-5.61280.9975-6.6894-44.1827-92.2554-149.3625
EBITDA Margin-2.00173.2364-4.9108-43.0926-90.8603-146.948
Pre-Tax Profit Margin-5.74350.8534-7.1291-44.5461-92.5953-146.8239
Net Profit Margin-6.14820.4729-7.2921-44.6694-93.418-148.2568
Asset Turnover1.5482.40282.50571.92371.93560.7357
Inventory Turnover Ratio------
Receiveable Turnover6.73446.18395.16756.7778.52298.3613
Days Sales In Receivables54.199559.024170.634153.858342.82643.6534
ROE - Return On Equity-37.1385.7194-49119.63-1720.998-4389.115-163.0476
Return On Tangible Equity-39.63488.1581221.62172559.1042423.665-177.8078
ROA - Return On Assets-9.51761.1363-18.2719-85.9319-180.8205-109.0728
ROI - Return On Investment-37.1385.7194-7380-1721-4389.076-163.0475
Book Value Per Share0.41790.19260.00030.03640.02730.9271
Operating Cash Flow Per Share0.11320.24360.15430.47120.872-0.9926
Free Cash Flow Per Share-0.01510.2960.11440.43650.8541-0.9697